Nonmyocytes as electrophysiological contributors to cardiac excitation and conduction

A Simon-Chica, EM Wülfers… - American Journal of …, 2023 - journals.physiology.org
Although cardiac action potential (AP) generation and propagation have traditionally been
attributed exclusively to cardiomyocytes (CM), other cell types in the heart are also capable …

Ischemia–Reperfusion Injury: Molecular Mechanisms of Pathogenesis and Methods of Their Correction

RG Goncharov, MG Sharapov - Molecular Biology, 2023 - Springer
Ischemia–reperfusion is a cascade of complex and interrelated pathological processes
underlying many human diseases, including such socially significant diseases as stroke …

[HTML][HTML] Lipidomic Predictors of Coronary No-Reflow

A Surendran, U Ismail, N Atefi, AK Bagchi, PK Singal… - Metabolites, 2023 - mdpi.com
The 'no-reflow'phenomenon (NRP) after primary percutaneous coronary intervention (PCI) is
a serious complication among acute ST-segment elevation myocardial infarction (STEMI) …

Review of cardiac–coronary interaction and insights from mathematical modeling

L Fan, H Wang, GS Kassab… - WIREs Mechanisms of …, 2024 - Wiley Online Library
Cardiac–coronary interaction is fundamental to the function of the heart. As one of the
highest metabolic organs in the body, the cardiac oxygen demand is met by blood perfusion …

The fate and role of the pericytes in myocardial diseases

NG Frangogiannis - European Journal of Clinical Investigation, 2024 - Wiley Online Library
The adult mammalian heart contains a large population of pericytes that play important roles
in homeostasis and disease. In the normal heart, pericytes regulate microvascular …

[HTML][HTML] Establishment and verification of a nomogram that predicts the risk for coronary slow flow

J Yu, Y Ran, D Yi, C Yang, X Zhou, S Wang… - Frontiers in …, 2024 - frontiersin.org
Background Coronary slow flow (CSF) has gained significance as a chronic coronary artery
disease, but few studies have integrated both biological and anatomical factors for CSF …

Advanced technique of myocardial no-reflow quantification using indocyanine green

D Sonin, G Papayan, M Istomina, I Anufriev… - Biomedical Optics …, 2024 - opg.optica.org
The post-ischemic no-reflow phenomenon after primary percutaneous coronary intervention
(PCI) is observed in more than half of subjects and is defined as the absence or marked …

[PDF][PDF] 肝素早期预处理对急诊介入治疗STEMI 患者梗死相关血管血流及对炎性因子和远期心功能影响

肖立运, 李秀丽, 许胜 - 临床急诊杂志, 2023 - lcjz.whuhzzs.com
目的: 探讨肝素早期预处理对急诊介入治疗急性ST 段抬高型心肌梗死(
STsegmentelevationmyocardialinfarction, STEMI) 患者的梗死相关血管(infarctrelatedartery …

Assessing the Effects of Ischemia-Reperfusion in Multicellular Cardiovascular Tissues In Vitro

R Yee - 2023 - search.proquest.com
Transplanting exogenous cardiomyocytes into the infarcted myocardium is a promising
strategy to prevent and potentially cure heart failure. However, many cardiomyocytes …

Investigation of the relationship between modified Glasgow prognostic score and no-reflow phenomenon in patients undergoing primary percutaneous coronary …

M Kaplangoray, K Toprak, C AYDIN… - The European Research …, 2023 - dergipark.org.tr
Objectives: No-reflow phenomenon (NRP) is a complication associated with poor clinical
outcome in patients with ST-segment elevation myocardial infarction (STEMI) undergoing …